FDA Approved: PORTIA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PORTIA, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submitted by Teva Pharmac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• PORTIA (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for PORTIA (LEVONORGESTREL AND ETHINYL ESTRADIOL)